Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Eosinophilia with DTIC chemotherapy

M A Movsesian, J M Merrill

    Annals of Internal Medicine
    |October 1, 1980
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Phosphodiesterase 4 interacts with the 5-HT4(b) receptor to regulate cAMP signaling.

    Cellular signalling·2014
    Same author

    Perceived effectiveness of counselling patients about smoking among medical students in Amman, Jordan.

    Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit·2010
    Same author

    Utility of long-term surveillance endomyocardial biopsy: a multi-institutional analysis.

    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2006
    Same author

    Identification of a novel isoform of the cyclic-nucleotide phosphodiesterase PDE3A expressed in vascular smooth-muscle myocytes.

    The Biochemical journal·2000
    Same author

    Thanatophobia and opiophobia of hospice nurses compared with that of other caregivers.

    The American journal of hospice & palliative care·2000
    Same author

    Therapeutic potential of cyclic nucleotide phosphodiesterase inhibitors in heart failure.

    Expert opinion on investigational drugs·2000